• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

博氏线与新型冠状病毒肺炎;关于它们之间关联的系统评价

Beau's Lines and COVID-19; A Systematic Review on Their Association.

作者信息

Agouridis Aris P, Mastori-Kourmpani Christina, Antoniou Polyna, Konstantinou Paschalis, Rizos Evangelos C, Tsioutis Constantinos

机构信息

School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.

Department of Internal Medicine, German Oncology Center, 4108 Limassol, Cyprus.

出版信息

Pathogens. 2024 Mar 20;13(3):265. doi: 10.3390/pathogens13030265.

DOI:10.3390/pathogens13030265
PMID:38535608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10974365/
Abstract

BACKGROUND

Beau's lines are transverse grooves in the nail plate that result from transient interruption of the growth of the proximal nail matrix after severe disease. The aim of this study is to systematically report all evidence on the association of Beau's lines with COVID-19 infection or vaccination against COVID-19.

METHODS

PubMed and Scopus databases were searched up to January 2024 for articles reporting Beau's lines associated with COVID-19 infection or vaccination for COVID-19.

PROSPERO ID

CRD42024496830.

RESULTS

PubMed search identified 299 records while Scopus search identified 18 records. After screening the bibliography, nine studies including 35 cases were included in our systematic review. The studies were reported from different areas around the world. Included studies documented Beau's lines following COVID-19 vaccination (two studies) or after COVID-19 infection (seven studies). High variability was recorded in onset and resolution times among included cases, averaging 3 months and 6 months after COVID-19 infection, respectively. In the two studies reporting Beau's lines after vaccination, onset was at 7 days and 6 weeks and resolution occurred after 8 and 17 weeks, respectively.

CONCLUSIONS

To the best of our knowledge, this is the first systematic review reporting the association of Beau's lines with COVID-19 infection and vaccination. Severe immune response can result in the formation of these nail disorders. Of importance, Beau's lines represent a potential indicator of prior severe COVID-19 infection or vaccination for COVID-19, as well as a sign of long COVID-19 syndrome.

摘要

背景

博氏线是指甲板上的横向凹槽,由严重疾病后近端甲母质生长的短暂中断引起。本研究的目的是系统地报告所有关于博氏线与新冠病毒感染或新冠病毒疫苗接种之间关联的证据。

方法

截至2024年1月,在PubMed和Scopus数据库中搜索报告与新冠病毒感染或新冠病毒疫苗接种相关的博氏线的文章。

国际前瞻性系统评价注册编号

CRD42024496830。

结果

PubMed搜索识别出299条记录,Scopus搜索识别出18条记录。在筛选文献后,我们的系统评价纳入了9项研究,共35例病例。这些研究来自世界各地不同地区。纳入的研究记录了新冠病毒疫苗接种后(两项研究)或新冠病毒感染后(七项研究)出现的博氏线。纳入病例的发病和消退时间差异很大,新冠病毒感染后平均分别为3个月和6个月。在两项报告疫苗接种后出现博氏线的研究中,发病时间分别为7天和6周,消退时间分别为8周和17周。

结论

据我们所知,这是第一项系统评价博氏线与新冠病毒感染和疫苗接种之间关联的研究。严重的免疫反应可导致这些指甲疾病的形成。重要的是,博氏线是既往严重新冠病毒感染或新冠病毒疫苗接种的潜在指标,也是新冠后综合征的一个迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/411b2e3a45e3/pathogens-13-00265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/e67453ad0d08/pathogens-13-00265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/ca2c1b1bba76/pathogens-13-00265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/411b2e3a45e3/pathogens-13-00265-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/e67453ad0d08/pathogens-13-00265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/ca2c1b1bba76/pathogens-13-00265-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570b/10974365/411b2e3a45e3/pathogens-13-00265-g003.jpg

相似文献

1
Beau's Lines and COVID-19; A Systematic Review on Their Association.博氏线与新型冠状病毒肺炎;关于它们之间关联的系统评价
Pathogens. 2024 Mar 20;13(3):265. doi: 10.3390/pathogens13030265.
2
Dermatology (Beau's Lines) and Forensic Pathology (Harris Lines and Linear Enamel Hypoplasia) Signs of Growth Arrest: A Case Report and Literature Review.皮肤病学(博氏线)与法医病理学(哈里斯线和线性釉质发育不全)生长停滞迹象:病例报告及文献综述
Cureus. 2025 Jun 1;17(6):e85190. doi: 10.7759/cureus.85190. eCollection 2025 Jun.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Vaccines for preventing infections in adults with haematological malignancies.用于预防血液系统恶性肿瘤成人感染的疫苗。
Cochrane Database Syst Rev. 2025 May 21;5(5):CD015530. doi: 10.1002/14651858.CD015530.pub2.
5
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
6
Inhaled corticosteroids for the treatment of COVID-19.吸入性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Mar 9;3(3):CD015125. doi: 10.1002/14651858.CD015125.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.

本文引用的文献

1
Unravelling Beau's Lines as a Potential Indicator of Severe Immune Response in Covid-19 and Reinfection.解读博氏线作为新冠病毒感染及再感染中严重免疫反应的潜在指标
Eur J Case Rep Intern Med. 2024 Jan 17;11(2):004281. doi: 10.12890/2024_004281. eCollection 2024.
2
Beau's Lines and Onychomadesis: A Systematic Review of Characteristics and Aetiology.博氏线与甲脱落:特征及病因的系统评价
Acta Derm Venereol. 2023 Oct 30;103:adv18251. doi: 10.2340/actadv.v103.18251.
3
The immunology of long COVID.长新冠的免疫学
Nat Rev Immunol. 2023 Oct;23(10):618-634. doi: 10.1038/s41577-023-00904-7. Epub 2023 Jul 11.
4
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
5
The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.COVID-19 对毛发和甲疾病发展的影响:一项土耳其多中心、对照研究。
Int J Dermatol. 2023 Feb;62(2):202-211. doi: 10.1111/ijd.16454. Epub 2022 Oct 25.
6
Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination.新冠疫苗接种后的横向白甲和博氏线
Cutis. 2022 Aug;110(2):E28-E31. doi: 10.12788/cutis.0606.
7
Transition beyond the acute phase of the COVID-19 pandemic: Need to address the long-term health impacts of COVID-19.超越新冠疫情急性期:需应对新冠疫情的长期健康影响。
World J Clin Cases. 2022 Sep 26;10(27):9967-9969. doi: 10.12998/wjcc.v10.i27.9967.
8
Long covid-an update for primary care.长新冠——基层医疗的最新情况
BMJ. 2022 Sep 22;378:e072117. doi: 10.1136/bmj-2022-072117.
9
Beau's line in COVID-19 after a long ICU stay.新冠肺炎患者在 ICU 长时间治疗后出现脑白质疏松症。
Nutr Hosp. 2022 Aug 25;39(4):945-948. doi: 10.20960/nh.04131.
10
Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine.第二剂辉瑞-生物科技公司的BNT162b2新冠信使核糖核酸疫苗引发新发甲银屑病病例。
JAAD Case Rep. 2021 Nov;17:18-20. doi: 10.1016/j.jdcr.2021.09.009. Epub 2021 Sep 22.